When you read the fine print and do your homework it becomes blatantly clear that such faith in the assumed omnipotence of these professionals and their associations is questionable at best. "Conflict of Interest" is rife in our governments and professional associations. So much so that the question becomes "Who do you trust?"
CBC and other news agencies have spent months tracking down the truth about Tamiflu, the Be-all, End-all for dealing with the H1N1 flu virus..... or so they tried to convince us. The Canadian government stockpiled nearly $180 MILLION dollars worth of anti-viral drugs (mostly Tamiflu), and now a good portion of it is about to expire. Yep, Millions of dollars are about to be thrown out. Why do we have these stockpiles of drugs and are they even worth it is the question the CBC and other media reporters are asking. Why? Because the truth is that there is a HUGE conflict of interest that is deeply rooted at the centre of all this.
The CBC reports:
A CBC documentary, which was broadcast on The National on Monday night, reports that certain other researchers in Canada, Italy, Britain and the U.S. are now challenging the claims by Roche that Tamiflu can significantly reduce complications or hospitalizations due to the flu.
The documentary also raises concerns about possible side effects surrounding the drug — strange behaviours and psychiatric delusions — that some countries, Japan in particular, have reported.
Using freedom of information requests, the investigation found hundreds of similar cases in Canada and the U.S., which were reported to health authorities but have not been made public.
It’s often difficult to establish a clear causal link between a drug and rare adverse reactions. Roche says its research suggests that these side effects result from the flu itself and high fevers, not the medication.
In the course of the CBC investigation, Zalac also reported that three of Canada's most prominent flu experts — Dr. Donald Low and Dr. Allison McGeer of Mount Sinai Hospital in Toronto, and Dr. Fred Aoki of the University of Manitoba — had received research funding or acted as a consultant or speaker for Roche during the period when Tamiflu was being promoted....
...But these relationships were rarely reported in broader public forums, in the media or even when some of these individuals would appear in marketing videos or flu-warning commercials on television produced by Roche.